Available in 12
locations and 7
Unified Patent Court Preparatory Committee issues rules on court fees and recovery of costs
Patent Update & Alert
The Court of Appeal has upheld the invalidity of a Rovi patent on the grounds of obviousness
The Patents Court has rejected Warner-Lambert’s conditional application to amend its patent relating to pregabalin.
The Patents Court has upheld the validity of a patent directed to the use of atomoxetine for the treatment of ADHD
European Commission report on patent settlements in the pharmaceuticals sector warns of competition law concerns but suggests that intervention is unlikely.
In a rare patent case in the fashion sector, the Patents Court has decided that three styles of H&M bras infringe a patent relating to the tubular fabric 更多
The Patents Court has granted Actavis a declaration in relation to its new pemetrexed product in its dispute with Eli Lilly.
Member states have agreed the distribution of renewal fees for the Unitary Patent.
With the UPC expected to be in operation from early 2017, what are the key outstanding issues?
The Patents Court has granted an interim injunction in respect of dealings in full label generic pregabalin products.
The Patents Court has decided that a patent relating to capsules used in a dry powder inhaler is invalid.
The Patents Court has rejected a validity attack against a patent relating to immunotherapy treatment for cancer.
The Commission confirms it is considering introduction of a Unitary SPC and consider recalibration of the SPC regime.